Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Kala Y Kamdar"'
Autor:
Kayla L Foster, Kathleen D Kern, Tiffany M Chambers, Philip J Lupo, Kala Y Kamdar, Michael E Scheurer, Austin L Brown
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0217932 (2019)
BackgroundAs survival rates for childhood acute lymphoblastic leukemia (ALL) continue to improve, there is growing concern over the chronic health conditions that survivors face. Given that survivors of childhood ALL are at increased risk of cardiova
Externí odkaz:
https://doaj.org/article/9a650cc59b964975b847038ce3ca6fb2
Autor:
Kevin E. Fisher, Lizmery S. Ferguson, Amy M. Coffey, Brian Y. Merritt, Jonathan L. Curry, Andrea N. Marcogliese, Angela M. Major, Kala Y. Kamdar, Dolores H. Lopez-Terrada, Choladda V. Curry
Publikováno v:
Haematologica, Vol 107, Iss 8 (2022)
Programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) are immunomodulatory molecules overexpressed in lymphomas and are promising immunotherapy targets for hematologic malignancies. However, studies of PD-1/PD-L1 overexpression an
Externí odkaz:
https://doaj.org/article/4acae81cae8a448f82cf0d0b57fc9a8d
Autor:
Mark Zobeck, M. Brooke Bernhardt, Kala Y. Kamdar, Karen R. Rabin, Philip J. Lupo, Michael E. Scheurer
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 43:205-214
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e345544e31effee151f88aaebf535ad9
https://doi.org/10.1002/phar.2779
https://doi.org/10.1002/phar.2779
Autor:
Albert C. Chen, MD, PhD, M. Fatih Okcu, MD, MPH, ZoAnn E. Dreyer, MD, Kala Y. Kamdar, MD, Rona Y. Sonabend, MD, Hilary S. Suzawa, MD, Eunji Jo, MS, Arnold C. Paulino, MD
Publikováno v:
Advances in Radiation Oncology, Vol 2, Iss 2, Pp 228-234 (2017)
Purpose: To compare the effect of 12 versus 18 Gy cranial radiation therapy (RT) on height and weight indices among pediatric patients with acute lymphoblastic leukemia (ALL). Methods and materials: Records of children with ALL who were 2 to 14 years
Externí odkaz:
https://doaj.org/article/04bd83dbfbbf4a8ca82da7690b3f99a9
Autor:
Emily M. Mace, Carl E. Allen, R. Helen Rouce, Asbjørg Stray-Pedersen, Jordan S. Orange, Shalini N. Jhangiani, Olive S. Eckstein, Kenneth L. McClain, M. Cecilia Poli, Ivan K. Chinn, Hey Chong, Nmazuo W. Ozuah, Jason W. Caldwell, Lisa R. Forbes, Erin C. Peckham-Gregory, Tiphanie P. Vogel, Nader Kim El-Mallawany, Juan C. Aldave-Becerra, Joseph Lubega, Jennifer E. Agrusa, Helen E. Heslop, Zeynep H. Coban-Akdemir, James R. Lupski, Francesco Saettini, Nicholas L. Rider, Stephen Jolles, Natalia S. Chaimowitz, Donna M. Muzny, Richard A. Gibbs, Kala Y. Kamdar, Nitya Gulati
Publikováno v:
J Allergy Clin Immunol
Background Pediatric nonmalignant lymphoproliferative disorders (PLPDs) are clinically and genetically heterogeneous. Long-standing immune dysregulation and lymphoproliferation in children may be life-threatening, and a paucity of data exists to guid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::557d325f1c5b9f5ddf4f28929e2c5b8b
https://doi.org/10.1016/j.jaci.2021.07.015
https://doi.org/10.1016/j.jaci.2021.07.015
Autor:
Melissa A. Richard, Sogol Mostoufi-Moab, Nisha Rathore, Jessica Baedke, Austin L. Brown, Stephen J. Chanock, Danielle N. Friedman, M. Monica Gramatges, Rebecca M. Howell, Kala Y. Kamdar, Wendy M. Leisenring, Lillian R. Meacham, Lindsay M. Morton, Kevin Oeffinger, Leslie L. Robison, Yadav Sapkota, Charles A. Sklar, Gregory T. Armstrong, Smita Bhatia, Philip J. Lupo
Publikováno v:
JCO precision oncology. 6
PURPOSE To characterize germline genetic risk factors of diabetes mellitus among long-term survivors of childhood cancer. METHODS Adult survivors of childhood cancer from the Childhood Cancer Survivor Study (CCSS) Original Cohort (n = 5,083; 383 with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7a65be30b2ea1408ff97ea098825742
https://pubmed.ncbi.nlm.nih.gov/36480781
https://pubmed.ncbi.nlm.nih.gov/36480781
Publikováno v:
Pediatrics In Review. 42:S89-S92
1. Julia D. Blood, MD* 2. Adrita Khan, MD† 3. Kala Kamdar, MD* 4. Dana M. Foradori, MD, M. Ed* 1. *Department of Pediatrics, Baylor College of Medicine, Texas Children’s Hospital, Houston, TX 2. †Department of Pediatrics, Columbia University Ir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd0b08b1aec308546757c6c66c75c2f5
https://doi.org/10.1542/pir.2019-0200
https://doi.org/10.1542/pir.2019-0200
Autor:
K Danielle Aldrich, Philip J. Lupo, Kayla L. Foster, Hoda Badr, Austin L. Brown, Abiodun Oluyomi, Michael E. Scheurer, Kala Y. Kamdar
Publikováno v:
J Cancer Surviv
PURPOSE: Area deprivation index (ADI), a measure of neighborhood socioeconomic disadvantage, has been linked to metabolic outcomes in the general population, but has received limited attention in survivors of childhood acute lymphoblastic leukemia (A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a8a3455aee1102b8b2ccbc860a49abc
https://doi.org/10.1007/s11764-020-00968-7
https://doi.org/10.1007/s11764-020-00968-7
Autor:
C. Karsenty, T. Kim, N. Gulati, M. Shapiro, A. Sher, C. Curry, J. Brackett, J. Agrusa, O. Eckstein, J. Margolin, R. Rouce, Z. Dreyer, J. Dajac, T. Chanroo, Austyn T. Grim, Erin L. Peckham-Gregory, Nmazuo W. Ozuah, Kenneth L. McClain, C. Allen, N. El-Mallawany, Kala Y. Kamdar
Publikováno v:
Leukemia Research. 121:S58
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c1a4503f89cfeef3d0c6cf98e052bcd
https://doi.org/10.1016/s0145-2126(22)00289-2
https://doi.org/10.1016/s0145-2126(22)00289-2
Autor:
Priya Mahajan, Kiranmye Reddy, Karen R. Rabin, Julienne Brackett, Ankhi Dutta, Kala Y. Kamdar, Hana Paek, Maria M. Gramatges, Debra L. Palazzi, Michael E. Scheurer, Ashley Ikwuezunma, Ann M Marshburn, Maria I Castellanos
Publikováno v:
Pediatric Blood & Cancer. 68
Background: Children with hematologic malignancies, especially those who receive intensive chemotherapy, are at high risk for invasive mold infections (IMI) that confer substantial mortality. Randomized controlled trials support the use of anti-funga
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1afed0642a26d0d9fdda6a8a0bcabe2
https://doi.org/10.1002/pbc.29228
https://doi.org/10.1002/pbc.29228